Alisa Budin

Alisa Budin is a seasoned marketing professional with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Global Marketing and Head of Innovative Pipeline Optimization at Teva Pharmaceuticals since November 2015, Alisa leads the commercial development of the company's neuroscience and immunology assets. Previously, Alisa held various senior roles at Shire Pharmaceuticals, including Senior Director of Global Marketing & Portfolio and Senior Global Brand Director, focusing on ADHD products. Alisa's career also includes strategic consulting at Beckman Pharmaceutical Consulting and significant marketing roles at Elan Pharmaceuticals, ALZA Corporation, and Pfizer, where contributions included the launch strategies for notable products like Tysabri and Concerta. Alisa holds an MBA from Harvard Business School and a BS in Economics from the University of Pennsylvania.